Mr. Joshua Hill reports

NDATALYZE CORP. ("NDAT" OR THE "CORPORATION") (CSE:NDAT) (OTC:NDATF) UPDATES THE PROGRESS OF ADVANCED TMS PROGRAMS IN THE U.S. BY ITS MINDBALANCED, INC. SUBSIDIARY.

Ndatalyze Corp. has provided an update on the operations of its 100-per-cent-owned Mindbalanced Inc. subsidiary.

The following is for operational update purposes only and is not necessarily material.

Joshua Hill, NDAT and Mindbalanced Inc. President, reports: " Our overall solution involves collaborative partnerships with mental health-related facilities, clinics, and clinicians seeking effective and personalized treatment plans for drug-resistant patients. We consult with the entire program, and our revenue-sharing business model benefits customers by saving time, providing state-of-the-art tools, offering personalized treatment protocols, and adding an additional revenue stream. We anticipate significant growth in revenues from private and public medical insurance programs as mental health benefits are incorporated into more insurance plans. Lastly, we anticipate adding substantial biometric, DNA, and TMS treatment response data to our database. This data will be instrumental in advancing clinical research and developing personalized treatment protocols, ultimately leading to improved patient outcomes."

Mindbalanced's current sales pipeline includes two large healthcare facilities in the Southeast US catering to a patient base of over 2,000 candidates; a major psychiatric hospital in South Florida; and a partnering network in Alabama that serves over 10,000 active patients. The "prospect-to-revenue" cycle is expected to be approximately 120 days with Mindbalanced being well into the cycle with multiple prospects. While none of these prospects are yet under contract they are disclosed to inform investors as to what Mindbalanced's prospecting activity looks like.

Joshua Hill, NDAT and Mindbalanced Inc. President, adds: Leading manufacturers of TMS often use a consumable model that imposes a significant financial strain on facilities thereby reducing patient access to these treatments. In contrast, our non-consumable model means facilities do not pay per treatment, making TMS more accessible and affordable for patients. Our aim is to onboard and launch a new facility every thirty days. This strategy allows the implementation team time to thoroughly consult with potential partners and their staff, ensuring a seamless and effective integration of Mindbalanced's TMS programs."

For Further Information, please contact: Joshua Hill, President Email: josh@mindbalanced.org Tel: (786) 714-4811 Mindbalanced Website: https://mindbalanced.org YMI Website: https://ymihealth.ca nDatalyze Website: https://www.ndatalyze.com

About Mindbalanced, Inc.:

Mindbalanced's vision is to redefine mental healthcare through an integrative, personalized approach leveraging cutting edge technology and non-invasive treatment protocols. By harnessing evidence-based data we aim to predict and enhance mental wellbeing, taking into account individual predispositions and environmental factors thereby fostering healthier and more fulfilling lives for all.

About YMI:

YMI uses evidence-based, objective data from whole life experiences to predict individual mental states over time and applies this knowledge towards a fuller understanding of how mental health develops, and how to improve mental wellbeing. YMI combines supervised machine-learning with a proprietary Reference Database to predict an individual's predisposition toward a variety of common mental conditions, both current and forward in time.

YMI is poised to revolutionize mental health diagnoses while ensuring a sustainable revenue stream. By strategically addressing the causes of misdiagnosis, establishing credibility through clinical studies, and targeting key markets, YMI aligns both societal impact and financial success.

We seek Safe Harbor.